PT Multi Medika Internasional Tbk (IDX:MMIX)
785.00
+5.00 (0.64%)
Last updated: Sep 2, 2026, 1:32 PM WIB
IDX:MMIX Ratios and Metrics
Market cap in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,744,332 | 1,075,295 | 312,028 | 480,018 | 873,600 | - | |
Market Cap Growth | 473.53% | 244.61% | -35.00% | -45.05% | - | - |
Enterprise Value | 3,920,988 | 1,256,115 | 491,390 | 513,198 | 871,054 | - |
Last Close Price | 780.00 | 224.00 | 65.00 | 100.00 | 182.00 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 741.93 | 205.27 | 258.52 | 29.07 | 36.91 | - |
PS Ratio | 19.39 | 5.34 | 1.63 | 2.74 | 4.99 | - |
PB Ratio | 19.93 | 5.78 | 1.73 | 2.68 | 5.36 | - |
P/TBV Ratio | 20.03 | 5.83 | 1.76 | 2.75 | 5.40 | - |
P/FCF Ratio | 244.97 | 23.46 | - | - | - | - |
P/OCF Ratio | 242.24 | 23.27 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 20.30 | 6.24 | 2.56 | 2.93 | 4.97 | - |
EV/EBITDA Ratio | 34.94 | 11.07 | 18.53 | 17.50 | 27.15 | - |
EV/EBIT Ratio | 132.10 | 40.02 | 25.36 | 20.14 | 27.83 | - |
EV/FCF Ratio | 256.53 | 27.40 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.96 | 0.99 | 1.07 | 0.72 | 0.07 | 0.10 |
Debt / EBITDA Ratio | 1.61 | 1.61 | 6.94 | 4.25 | 0.34 | 0.07 |
Debt / FCF Ratio | 11.82 | 4.02 | - | - | - | 0.53 |
Net Debt / Equity Ratio | 0.94 | 0.83 | 1.05 | 0.36 | -0.42 | 0.03 |
Net Debt / EBITDA Ratio | 1.59 | 1.36 | 7.14 | 2.20 | -2.15 | 0.03 |
Net Debt / FCF Ratio | 11.56 | 3.37 | -1.52 | -0.59 | 1.66 | 0.19 |
Asset Turnover | 0.46 | 0.49 | 0.52 | 0.67 | 1.14 | 3.23 |
Inventory Turnover | 0.34 | 0.35 | 0.44 | 0.73 | 1.93 | 5.97 |
Quick Ratio | 1.19 | 1.63 | 2.06 | 1.52 | 3.99 | 0.81 |
Current Ratio | 5.60 | 6.96 | 9.65 | 3.56 | 5.56 | 1.26 |
Return on Equity (ROE) | 2.73% | 2.86% | 0.67% | 9.64% | 24.99% | 180.50% |
Return on Assets (ROA) | 4.43% | 4.75% | 3.30% | 6.10% | 12.78% | 37.14% |
Return on Invested Capital (ROIC) | 5.84% | 5.92% | 4.28% | 11.56% | 40.06% | 183.17% |
Return on Capital Employed (ROCE) | 8.00% | 8.40% | 5.20% | 10.60% | 19.10% | 124.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.13% | 0.49% | 0.39% | 3.44% | 2.71% | - |
FCF Yield | 0.41% | 4.26% | -39.93% | -22.92% | -4.76% | - |
Buyback Yield / Dilution | 0.21% | -0.00% | -38.90% | 13.62% | -21.98% | - |